Pain Pharmacotherapy in Patients with Inflammatory Arthritis and Concurrent Cardiovascular or Renal Disease: A Cochrane Systematic Review

Jonathan L. Marks(University Hospital Southampton NHS Foundation Trust), Christopher J Edwards(University Hospital Southampton NHS Foundation Trust), D. M. van der HEIJDE(Leiden University Medical Center), Rachelle Buchbinder(Institute for Musculoskeletal Health), Alexandra N. Colebatch(University Hospital Southampton NHS Foundation Trust)
Journal of Rheumatology Supplement
September 1, 2012
10.3899/jrheum.120347
Cited by 15

Related Papers

A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010
|The Lancet|2012|12k
What low back pain is and why we need to pay attention
|The Lancet|2018|4.7k
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update
|Annals of the Rheumatic Diseases|2020|2.8k
Prevention and treatment of low back pain: evidence, challenges, and promising directions
|The Lancet|2018|2.5k
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update
|Annals of the Rheumatic Diseases|2022|1.9k